CLSD
Clearside Biomedical, Inc.
NASDAQ · Healthcare · Biotechnology · US
$0.41
+0.00%Margins
Gross margin
85.6%
EBITDA margin
-431.5%
EBIT margin
-689.8%
Net margin
-780.9%
FCF margin
-653.0%
48.2%
Return on equity
-223.3%
Return on assets
42.9%
Return on invested capital
0.25x
Asset turnover
-$21.3M
Cash from operations
$1.30
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Sep 1, 2025